DETERMINATION OF ACETYLATOR STATUS IN URAEMIA.FINE A; SUMNER DJ.1975; BRIT. J. CLIN. PHARMACOL.; G.B.; DA. 1975; VOL. 2; NO 5; PP. 475-476; BIBL. 6 REF.Article

MEASUREMENT OF DIASTOLIC CLOSURE RATE OF NORMAL MITRAL VALVE = MESURE DE LA VITESSE DE FERMETURE DIASTOLIQUE DE LA VALVULE MITRALE NORMALERODGER JC; SUMNER DJ.1975; BRIT. HEART J.; G.B.; DA. 1975; VOL. 37; NO 5; PP. 504-513; BIBL. 18 REF.Article

ANALYSIS OF THE PRESSOR DOSE RESPONSESUMNER DJ; ELLIOTT HL; REID JL et al.1982; CLINICAL PHARMACOLOGY AND THERAPEUTICS; ISSN 0009-9236; USA; DA. 1982; VOL. 38; NO 4; PP. 450-458; BIBL. 13 REF.Article

DIGOXIN KINETICS IN PATIENTS WITH THYROID DYSFUNCTION.LAWRENCE JR; SUMNER DJ; KALK WJ et al.1977; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1977; VOL. 22; NO 1; PP. 7-13; BIBL. 22 REF.Article

DIGOXIN PHARMACOKINETICS: MULTICOMPARTMENTAL ANALYSIS AND ITS CLINICAL IMPLICATIONSSUMNER DJ; RUSSELL AJ; WHITING B et al.1976; BRIT. J. CLIN. PHARMACOL.; G.B.; DA. 1976; VOL. 3; NO 2; PP. 221-229; BIBL. 25 REF.Article

AN ASSESSMENT OF DIGOXIN RADIO-IMMUNOASSAY = EVALUATION DU DOSAGE RADIO-IMMUNOLOGIQUE DE LA DIGOXINEWHITING B; SUMNER DJ; GOLDBERG A et al.1973; SCOTT. MED. J.; G.B.; DA. 1973; VOL. 18; NO 3; PP. 69-74; BIBL. 25REF.Serial Issue

THE PREDICTION OF INDIVIDUAL SYSTOLIC TIME INTERVAL V HEART RATE REGRESSION EQUATIONSKELMAN AW; SUMNER DJ; WHITING B et al.1981; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1981; VOL. 12; NO 1; PP. 21-30; BIBL. 18 REF.Article

SYSTOLIC TIME INTERVAL V HEART RATE REGRESSION EQUATIONS USING ATROPINE: REPRODUCIBILITY STUDIESKELMAN AW; SUMNER DJ; WHITING B et al.1981; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1981; VOL. 12; NO 1; PP. 15-20; BIBL. 12 REF.Article

ABSENCE OF AN EFFECT OF MIANSERIN ON THE ACTIONS OF CLONIDINE OR METHYLDOPA IN HYPERTENSIVE PATIENTSELLIOTT HL; MCLEAN K; SUMNER DJ et al.1983; EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY; ISSN 0031-6970; DEU; DA. 1983; VOL. 24; NO 1; PP. 15-19; BIBL. 25 REF.Article

MEASUREMENT OF SYSTOLIC TIME INTERVALSKELMAN AW; SUMNER DJ; LAWRENCE JR et al.1978; BRIT. J. CLIN. PHARMACOL.; GBR; DA. 1978; VOL. 6; NO 6; PP. 549-550; BIBL. 7 REF.Article

PHARMACODYNAMIC STUDIES ON MIANSERIN AND ITS INTERACTION WITH CLONIDINEELLIOTT HL; MCLEAN K; REID JL et al.1981; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1981; VOL. 11; NO 1; PP. 122P; BIBL. 5 REF.Article

HAEMODYNAMIC EFFECTS OF BM 10.188, A NEW ORALLY ACTIVE INOTROPIC AGENT, IN HEALTHY VOLUNTEERSWHITING B; KELMAN AW; SUMNER DJ et al.1982; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1982-02; VOL. 2; PP. 529-532; BIBL. 12 REF.Article

PHARMACODYNAMIC STUDIES ON MIANSERIN AND ITS INTERACTION WITH CLONIDINEELLIOTT HL; MCLEAN K; SUMNER DJ et al.1981; EUR. J. CLIN. PHARMACOL.; ISSN 0031-6970; DEU; DA. 1981; VOL. 21; NO 2; PP. 97-102; BIBL. 32 REF.Article

COMPUTER-ASSISTED REVIEW OF DIGOXIN THERAPY IN THE ELDERLY.WHITING B; WANDLESS I; SUMNER DJ et al.1978; BRIT. HEART J.; G.B.; DA. 1978; VOL. 40; NO 1; PP. 8-13; BIBL. 19 REF.Article

CLINICAL EVALUATION OF ENDRALAZINE (BQ 22708), A NEW VASODILATOR, IN ESSENTIAL HYPERTENSIONELLIOTT HL; MCLEAN K; SUMNER DJ et al.1982; CLIN. EXP. HYPERTENS., PART A, THEORY PRACT.; ISSN 504157; USA; DA. 1982; VOL. 4; NO 8; PP. 1409-1418; BIBL. 10 REF.Article

A PHARMACODYNAMIC AND PHARMACOKINETIC ASSESMENT OF A NEW ALPHA -ADRENOCEPTOR ANTAGONIST, DOXAZOSIN (UK 33274) IN NORMOTENSIVE SUBJECTSELLIOTT HL; MEREDITH PA; SUMNER DJ et al.1982; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1982; VOL. 13; NO 5; PP. 699-703; BIBL. 6 REF.Article

COMPARATIVE PHARMACOKINETICS AND PHARMACODYNAMICS OF CARDIAC GLYCOSIDESKELMAN AW; SUMNER DJ; LONSDALE M et al.1980; BRIT. J. CLIN. PHARMACOL.; GBR; DA. 1980; VOL. 10; NO 2; PP. 135-143; BIBL. 26 REF.Article

TESTS OF PANCREATIC FUNCTION USING ⁷⁵SE-SELENOMETHIONINEKRASNER N; BRODIE MJ; SUMNER DJ et al.1976; ACTA HEPATO-GASTROENTEROL.; ALLEM.; DA. 1976; VOL. 23; NO 2; PP. 144-150; ABS. ALLEM.; BIBL. 27 REF.Article

PLACEBO-CONTROLLED TRIAL OF ATENOLOL IN TREATMENT OF PREGNANCY-ASSOCIATED HYPERTENSIONRUBIN PC; BUTTERS L; CLARK DM et al.1983; LANCET (THE). (BRITISH EDITION); ISSN 0140-6736; GBR; DA. 1983; NO 8322; PP. 431-434; BIBL. 19 REF.Article

THE INFLUENCE OF PROTEIN BINDING ON DISOPYRAMIDE CLEARANCEBRYSON SM; LAWRENCE JR; STEELE WH et al.1982; EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY; ISSN 0031-6970; DEU; DA. 1982; VOL. 23; NO 5; PP. 453-456; BIBL. 7 REF.Article

PROTEIN BINDING OF SALICYLATE IN CUTANEOUS HEPATIC PORPHYRIA.STEELE WH; BOOBIS SW; MOORE MR et al.1978; EUROP. J. CLIN. PHARMACOL.; GERM.; DA. 1978; VOL. 13; NO 4; PP. 309-313; BIBL. 17 REF.Article

THE PERCUTANEOUS ABSORPTION OF LEAD-203 IN HUMANS FROM COSMETIC PREPARATIONS CONTAINING LEAD ACETATE, AS ASSESSED BY WHOLE-BODY COUNTING AND OTHER TECHNIQUESMOORE MR; MEREDITH PA; WATSON WS et al.1980; FOOD COSMET. TOXICOL.; ISSN 0015-6264; GBR; DA. 1980; VOL. 18; NO 4; PP. 399-405; BIBL. 16 REF.Article